Matthew E Growdon1,2, Edie Espejo1,2, Bocheng Jing1,2, W John Boscardin2,3,4, Andrew R Zullo5,6,7,8, Kristine Yaffe2,4,9,10, Kenneth S Boockvar11,12,13, Michael A Steinman1,2. 1. Division of Geriatrics, University of California-San Francisco, San Francisco, California, USA. 2. San Francisco VA Medical Center, San Francisco, California, USA. 3. Department of Medicine, University of California-San Francisco, San Francisco, California, USA. 4. Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA. 5. Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA. 6. Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA. 7. Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, Rhode Island, USA. 8. Department of Pharmacy, Lifespan-Rhode Island Hospital, Providence, Rhode Island, USA. 9. Department of Psychiatry, University of California-San Francisco, San Francisco, California, USA. 10. Department of Neurology, University of California-San Francisco, San Francisco, California, USA. 11. The New Jewish Home, New York, New York, USA. 12. Icahn School of Medicine at Mount Sinai, New York, New York, USA. 13. James J. Peters VA Medical Center, Bronx, New York, USA.
Abstract
BACKGROUND: People with dementia (PWD) take medications that may be unnecessary or harmful. This problem can be addressed through deprescribing, but it is unclear if PWD would be willing to engage in deprescribing with their providers. Our goal was to investigate attitudes toward deprescribing among PWD. METHODS: This was a cross-sectional study of 422 PWD aged ≥65 years who completed the medications attitudes module of the National Health and Aging Trends Study (NHATS) in 2016. Proxies provided responses when a participant was unable to respond due to health or cognitive problems. Attitudinal outcomes comprised responses to two statements from the patients' attitudes toward deprescribing questionnaire and its revised version (representing belief about the necessity of one's medications and willingness to deprescribe); another elicited the maximum number of pills that a respondent would be comfortable taking. RESULTS: The weighted sample represented over 1.8 million PWD; 39% were 75 to 84 years old and 38% were 85 years or older, 60% were female, and 55% reported six or more regular medications. Proxies provided responses for 26% of PWD. Overall, 22% believed that they may be taking one or more medicines that they no longer needed, 87% were willing to stop one or more of their medications, and 50% were uncomfortable taking five or more medications. Attitudinal outcomes were similar across sociodemographic and clinical factors. PWD taking ≥6 medications were more likely to endorse a belief that at least one medication was no longer necessary compared to those taking <6 (adjusted probability 29% [95% confidence interval (CI), 22%-38%] vs. 13% [95% CI, 8%-20%]; p = 0.004); the same applied for willingness to deprescribe (92% [95% CI, 87%-95%] vs. 83% [95% CI, 76%-89%]; p = 0.04). CONCLUSIONS: A majority of PWD are willing to deprescribe, representing an opportunity to improve quality of life for this vulnerable population.
BACKGROUND: People with dementia (PWD) take medications that may be unnecessary or harmful. This problem can be addressed through deprescribing, but it is unclear if PWD would be willing to engage in deprescribing with their providers. Our goal was to investigate attitudes toward deprescribing among PWD. METHODS: This was a cross-sectional study of 422 PWD aged ≥65 years who completed the medications attitudes module of the National Health and Aging Trends Study (NHATS) in 2016. Proxies provided responses when a participant was unable to respond due to health or cognitive problems. Attitudinal outcomes comprised responses to two statements from the patients' attitudes toward deprescribing questionnaire and its revised version (representing belief about the necessity of one's medications and willingness to deprescribe); another elicited the maximum number of pills that a respondent would be comfortable taking. RESULTS: The weighted sample represented over 1.8 million PWD; 39% were 75 to 84 years old and 38% were 85 years or older, 60% were female, and 55% reported six or more regular medications. Proxies provided responses for 26% of PWD. Overall, 22% believed that they may be taking one or more medicines that they no longer needed, 87% were willing to stop one or more of their medications, and 50% were uncomfortable taking five or more medications. Attitudinal outcomes were similar across sociodemographic and clinical factors. PWD taking ≥6 medications were more likely to endorse a belief that at least one medication was no longer necessary compared to those taking <6 (adjusted probability 29% [95% confidence interval (CI), 22%-38%] vs. 13% [95% CI, 8%-20%]; p = 0.004); the same applied for willingness to deprescribe (92% [95% CI, 87%-95%] vs. 83% [95% CI, 76%-89%]; p = 0.04). CONCLUSIONS: A majority of PWD are willing to deprescribe, representing an opportunity to improve quality of life for this vulnerable population.
Authors: Simon J Griffin; Ann-Louise Kinmonth; Marijcke W M Veltman; Susan Gillard; Julie Grant; Moira Stewart Journal: Ann Fam Med Date: 2004 Nov-Dec Impact factor: 5.166
Authors: Ian A Scott; Sarah N Hilmer; Emily Reeve; Kathleen Potter; David Le Couteur; Deborah Rigby; Danijela Gnjidic; Christopher B Del Mar; Elizabeth E Roughead; Amy Page; Jesse Jansen; Jennifer H Martin Journal: JAMA Intern Med Date: 2015-05 Impact factor: 21.873
Authors: Ariel R Green; Cynthia M Boyd; Kathy S Gleason; Leslie Wright; Courtney R Kraus; Ruth Bedoy; Bianca Sanchez; Jonathan Norton; Orla C Sheehan; Jennifer L Wolff; Emily Reeve; Matthew L Maciejewski; Linda A Weffald; Elizabeth A Bayliss Journal: J Gen Intern Med Date: 2020-07-29 Impact factor: 5.128